Generated August 17, 2026 at 8:30 PM ET
· Covers August 17 trading day
· 10 of 191 ready 8-Ks selected
· AI-assisted overview
The day featured major corporate actions including the completion of the AvalonBay-EQR merger creating Vivmark Residential (VMRK), Universal Health Services' acquisition of Talkspace, and leadership changes at L3Harris and Valion Bio. Regulatory developments included Nasdaq delisting notices for Nexalin and Helix Acquisition, while Lexaria regained compliance. Fabrinet reported strong quarterly results with revenue up 45% year-over-year. Also, Aureus Greenway and Powerus announced SEC effectiveness for their merger.
LHX
L3HARRIS TECHNOLOGIES, INC. /DE/
leadership
negative
materiality 0.85
August 17, 2026, 7:30 AM ET
L3Harris appoints Sam Mehta CEO; Kubasik exits after conduct probe
- Sam Mehta named President and CEO effective Aug 17, 2026; also joins Board.
- Christopher Kubasik stepped down as Chairman/CEO after Board investigation found conduct inconsistent with Code of Conduct; no impact on financials.
- Lewis Hay III named Independent Chairman; Lauren Barnes (SMS) and Christopher Aebli (CSD) appointed segment presidents.
NXL
Nexalin Technology, Inc.
regulatory
negative
materiality 0.90
August 17, 2026, 9:00 AM ET
Nexalin receives Nasdaq delisting notice for equity shortfall; hearing set for Sept 1
- Stockholders' equity of $1,519,423 as of June 30, 2026, below $2,500,000 minimum required by Nasdaq Rule 5550(b)(1).
- Nasdaq also cites prior bid price deficiency; hearing before Panel scheduled for September 1, 2026.
- Company intends to present compliance plan at hearing; no assurance of continued listing.
AVB
AVALONBAY COMMUNITIES INC
M&A
positive
materiality 1.00
August 17, 2026, 4:01 PM ET
AvalonBay-EQR merger closes; Vivmark Residential debuts on NYSE as VMRK
- Merger of equals completed Aug 17, 2026; AvalonBay shareholders receive 2.793 Vivmark shares per AVB share.
- Vivmark begins trading Aug 18 on NYSE under VMRK; ~$51B equity market cap, ~$70B enterprise value.
- Combined portfolio: 184,000+ apartments, 11,100 under construction, $4.4B development pipeline.
UHS
UNIVERSAL HEALTH SERVICES INC
M&A
positive
materiality 0.85
August 17, 2026, 4:15 PM ET
UHS completes $5.25/share acquisition of Talkspace, creating behavioral health continuum
- UHS acquired Talkspace for $5.25 per share in cash; deal announced March 9, 2026, closed Aug 17, 2026.
- Financed with $400M delayed draw term loan plus revolver borrowings under existing credit agreement.
- Talkspace network: ~6,000 licensed providers, services available to 200M+ people across all 50 states, DC, Puerto Rico.
AGH
Aureus Greenway Holdings Inc
M&A
positive
materiality 0.80
August 17, 2026, 4:00 PM ET
Aureus Greenway and Powerus announce SEC effectiveness of S-4; closing expected early Oct 2026
- SEC declared Form S-4 effective Aug 12, 2026; closing expected early Oct 2026.
- Combined company to be renamed Powerus Corporation, trading on Nasdaq under PUSA.
- Powerus milestones: $2.5M DoW order for 1,500 FPV aircraft; $90M Air Force IDIQ for Guardian-2.
XAGE
Longevity Health Holdings, Inc.
litigation
positive
materiality 0.70
August 17, 2026, 9:57 AM ET
Longevity Health settles Puritan litigation; issues $2.35M 10% convertible notes
- Settlement with Puritan Partners resolves litigation pending since Nov 2023; parties to file dismissal without prejudice within 3 business days.
- Existing note and warrant exchanged for new 10% senior secured convertible notes, aggregate principal $2,350,000, maturing Feb 2028.
- CEO Ram Ajjarapu says litigation had hindered capital raising and strategic opportunities; resolution removes overhang and enables execution of commercial strategy.
HLXC
Helix Acquisition Corp. III
regulatory
negative
materiality 0.60
August 17, 2026, 5:20 PM ET
Helix Acquisition Corp. III receives Nasdaq delisting notice for failure to meet 300 total holders requirement
- Received Nasdaq notice on Aug 14, 2026 for non-compliance with Listing Rule 5452(a)(2)(A) requiring at least 300 total holders.
- Company has 45 calendar days to submit a plan to regain compliance; Nasdaq may grant up to 180-day extension.
- Class A ordinary shares continue trading on Nasdaq under symbol HLXC as of Aug 17, 2026; no imminent delisting.
LEXX
Lexaria Bioscience Corp.
regulatory
positive
materiality 0.60
August 17, 2026, 12:37 PM ET
Lexaria regains Nasdaq bid price compliance; hearing cancelled, stock remains listed
- Received Nasdaq letter on Aug 17, 2026 confirming compliance with Rule 5550(a)(2) bid price requirement.
- Previously requested hearing before Nasdaq Hearings Advisor has been cancelled.
- Common stock (LEXX) continues trading on The Nasdaq Capital Market without interruption.
earnings
positive
materiality 0.90
August 17, 2026, 4:22 PM ET
Fabrinet Q4 revenue $1.316B (+45% YoY), FY26 revenue $4.64B (+36%); guides Q1 above
- Q4 FY26 revenue $1,315.8M, up 45% YoY from $909.7M; GAAP EPS $3.83, non-GAAP EPS $4.10.
- FY26 revenue $4.64B, up 36% YoY; GAAP net income $473.0M, non-GAAP EPS $14.09.
- Q1 FY27 guidance: revenue $1.375-1.425B, GAAP EPS $3.39-3.54, non-GAAP EPS $4.10-4.25.
leadership
negative
materiality 0.85
August 17, 2026, 6:04 AM ET
Valion Bio terminates CEO, appoints COO, secures $1.5M funding from 3i
- CEO Michael K. Handley terminated effective Aug 16, 2026; Lisa Wolf appointed COO, remains CFO.
- Letter Agreement with 3i, LP: $1.5M for 1,500 Series B Preferred at $1,000/share plus warrants.
- Second closing of $1.5M for another 1,500 shares if definitive side letter executed by Aug 24, 2026.